SARS-CoV-2 Ag Rapid Test-��綵�ؤ��e

��s��G2024/2/5

�U�է@�~�ɶ�

��@�~�y�{

��i�d��

��˪`�N�ƶ�

�D �� q ��

�� w �@ �~

��綵�جd��

��Y�g��

��˽ñг�i

�ӵ��Ī��P��

��U�׭q��i

�`��Ը߰��D

�z�O�� 2024/4/22��6570��X�� s��H��:126940 �W��s��H��:185611

SARS-CoV-2 Ag Rapid Test

��綵��	SARS-CoV-2 Ag Rapid Test	��N��	L72-919
��W��	�s��a��f�r�ܭ�ֳt�z��	��k	�K�̼h�R��R�k
��O	NPS (�аѾ\��Y�g��Ӫ�)	��k	Immunochromatography
��ˮe��	�s�a�f�r�ܭ�ֿz�M�ήM��	��į�	�аѾ\
��q	�@	�Ѧҭ�	Negative
��ˮɶ�	24�p�ɦ��	��
�ާ@�ɶ�	�Y�ɩʧ妸��	��O�s��
��i�ֵo	1�p��	��O�I��
��/�e�˪`�N�ƶ�	1�B�s�a�f�r�ܭ�ֿz�P�s�a�f�rPCR��˴ִΤ��P�A��V�� 2�B�f�H�m�W��ҽжK�b�s�a�f�r�ܭ�ֿz�M�κޤW 3�B�ХѱM�H�ǰe�A��n�ϥή�e�t�� 4�B�e�˻�� 5�B��˫ᾨ�t��30��e��	�Ƶ�	1.SARS-CoV-2�f�r��F�ӫ�: 1.26*10² TCID50/mL 2.Sensitivy: 83.3% (95%CI: 43.7% - 97.0%) 3.Specificity: 98.0% (95%CI: 89.5% - 99.6%)
�ާ@�էO	��G��˲�	�p��q��	2552
�[�@��L��綵��: ��A��		��s��	2021/6/8
�{�ɷN�q ��P�W��RT-PCR��~��{��G: Sensitivy: 83.3%�BSpecificity: 98.0%�A��g��100 TCID50/mL (��i�˥XCt�Ȥp��25.14��f�r�q)�C ��ʵ��G�A��ܰ��s��a��f�r�ܭ�C��ʪ��i��G�Ȼ��a��s��a��f�r�ܭ�C��յ��G��ư��P��L�f��X�ַP�V�C ��ʵ��G�A��ܵ��G�C�󰻴��A��s��a��f�r�ܭ�C��ʵ��G��ư��s��a��f�r�P�V��i��ʡA��z�L��l�E�_�覡�[�H�T�{�C �g��ɨ㦳�̰��f�r�q�A�Y��X�{�g��5��ˮe��ɭP��ʪ��G�C�t�~�A��T��Ķ��A��B�z�ιB��L�{��~�ҥi��\|��Ͱ��ʵ��G�C�аѾ\��CDC��iInterim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)�j

��Q�Ϥj�� 123 �� Ǥj��3�� / �X�ȯd�� / ��޲z�� Ĭ�ӷ�